BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11081260)

  • 1. Multiple papillary thyroid carcinoma metastases revealed on position emission tomography scan in a patient with negative 131I scan.
    Mechanick JI; Kim CK; Krynyckyi BR; Machac J; Urken ML
    Thyroid; 2000 Oct; 10(10):929-30. PubMed ID: 11081260
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
    Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
    Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
    Scott GC; Meier DA; Dickinson CZ
    J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.
    Alnafisi NS; Driedger AA; Coates G; Moote DJ; Raphael SJ
    J Nucl Med; 2000 Jun; 41(6):1010-5. PubMed ID: 10855626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
    Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
    J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma.
    Bakheet SM; Powe JE; Hammami MM; Ahmed M
    Clin Nucl Med; 1997 Jun; 22(6):438-9. PubMed ID: 9193832
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of concomitant metastases to kidney and erector spinae from papillary thyroid carcinoma using (131)I-SPECT and CT.
    Luo Q; Luo QY; Sheng SW; Chen LB; Yu YL; Lu HK; Zhu RS
    Thyroid; 2008 Jun; 18(6):663-4. PubMed ID: 18578619
    [No Abstract]   [Full Text] [Related]  

  • 9. [Papillary thyroid carcinoma metastasis to parapharyngeal lymph nodes: interest of the PET scan].
    Turner F; Paris J; Giovanni A; Zanaret M
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(3):175-8. PubMed ID: 17007192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor thrombus in the great veins from papillary carcinoma of the thyroid: 131I scan findings.
    Mugunthan N; Kumar AR; Thomas P
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2527-8. PubMed ID: 20525903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal metastasis secondary to papillary thyroid carcinoma.
    Koutkia P; Safer JD
    Thyroid; 2001 Nov; 11(11):1077-9. PubMed ID: 11762719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
    Feine U; Lietzenmayer R; Hanke JP; Wöhrle H; Müller-Schauenburg W
    Nuklearmedizin; 1995 Aug; 34(4):127-34. PubMed ID: 7675641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
    Malhotra G; Nair N; Awasare S; Baghel NS
    Clin Nucl Med; 2007 Jun; 32(6):488-90. PubMed ID: 17515766
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
    Rudavsky AZ; Freeman LM
    J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
    [No Abstract]   [Full Text] [Related]  

  • 15. Upper retropharyngeal node involvement in differentiated thyroid carcinoma demonstrated by 131I scintigraphy.
    Leger AF; Baillet G; Dagousset F; Vincenot MI; Izembart M; Clerc J; Barritault L
    Br J Radiol; 2000 Dec; 73(876):1260-4. PubMed ID: 11205668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131.
    Park HM; Perkins OW; Edmondson JW; Schnute RB; Manatunga A
    Thyroid; 1994; 4(1):49-54. PubMed ID: 8054861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic papillary thyroid carcinoma presenting as a long-standing calcified neck mass.
    Grosz AH; Sauer DA; Bliziotes MM; Cohen JI; Gross ND
    Thyroid; 2007 Aug; 17(8):799-800. PubMed ID: 17725440
    [No Abstract]   [Full Text] [Related]  

  • 18. Rectus abdominis muscle metastasis from papillary thyroid cancer identified by I-131 SPECT/CT.
    Zhao LX; Li L; Li FL; Zhao Z
    Clin Nucl Med; 2010 May; 35(5):360-1. PubMed ID: 20395716
    [No Abstract]   [Full Text] [Related]  

  • 19. I-131 whole body scintigraphy in a patient with micronodular pulmonary metastases from papillary thyroid carcinoma.
    Ruíz Hernández G; Vázquez Forner C; Fliquete Peris MV
    Nuklearmedizin; 2000; 39(1):40-1. PubMed ID: 10726257
    [No Abstract]   [Full Text] [Related]  

  • 20. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
    Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
    J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.